business

Experts Warn That Despite Low Forward P/E Ratio, Stocks May Not Be Cheap

07/10/2026, 09:37 AM business research
The current valuation of the S&P 500, with a forward price-earnings ratio of 21 compared to a trailing P/E of 28, suggests that investors are anticipating significant earnings growth in the coming year, which may not be realistic. This disparity raises concerns about potential market pullbacks if companies fail to meet these high expectations during the upcoming earnings season.
Abivax

Abivax Secures $920 Million Funding to Prepare for Independent U.S. Launch of Bowel Disease Drug, CEO Marc de Garidel Tells CNBC

07/10/2026, 03:36 AM business announcement biotech Abivax
Abivax has successfully raised $920 million, enabling it to independently pursue the U.S. launch of its bowel disease drug, obefazimod, without relying on a potential acquisition. This funding positions the company to finance operations through 2029 and address recent investor concerns regarding the drug's safety and efficacy.
JPMorgan Chase Goldman Sachs Morgan Stanley

Goldman Sachs and Other Firms Implement Policies to Mitigate Insider Trading Risks on Prediction Markets

Goldman Sachs has implemented a ban on employee trading in prediction markets related to the bank and other sensitive areas, reflecting growing concerns over insider trading risks in these platforms. This move highlights the need for companies to establish clear policies as regulatory scrutiny increases in this emerging market.